Defendant Name:
Nano-x Imaging Ltd.
Defendant Type:
Public Company
SIC Code:
9999
CUSIP:
M7070010
Document Reference:
comp25876
Document Details
Legal Case Name
SEC v. Nano-x Imaging Ltd. and Ran Poliakine
Document Name
Complaint
Document Date
29-Sep-2023
Document Format
Civil Proceeding
Case Number
23-cv-08611
Federal District Court
New York, Southern District of New York
Allegation Type
Issuer Reporting and Disclosure
Document Summary
The SEC alleged "From August 2020 through May 2021, Nanox, an Israel-based medical imaging company, and Poliakine, its founder and then CEO, negligently made a series of false and misleading statements to investors about the estimated cost to manufacture at least 15,000 units of its flagship product, the Nanox.ARC - a device the company is developing that it claimed would make diagnostic imaging substantially more affordable than currently available medical imaging systems and accessible to patients around the globe."
Other Defendants in Action:
